| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078299 Anti-cancer nitro- and thia-fatty acids |
| 04/24/2003 | US20030078289 Indole carboxylic acids as thyroid receptor ligands |
| 04/24/2003 | US20030078288 Indole derivatives |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects |
| 04/24/2003 | US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078260 2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists |
| 04/24/2003 | US20030078258 Adrenergic blocking agents |
| 04/24/2003 | US20030078254 Tricyclic inhibitors of poly(ADP-ribose) polymerases |
| 04/24/2003 | US20030078252 Used to treat abnormal cell growth and central nervous system disorders |
| 04/24/2003 | US20030078251 Triglyceride and cholesterol lowering activity and treats hyperlipidemia |
| 04/24/2003 | US20030078247 Enzyme inhibitor of a dipeptidyl peptidase for treating hyperglycaemia |
| 04/24/2003 | US20030078239 Ketone compounds and compositions for cholesterol management and related uses |
| 04/24/2003 | US20030078236 Arylsulfanyl and heteroarylsulfanyl derivatives for treating pain |
| 04/24/2003 | US20030078214 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 04/24/2003 | US20030078212 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 04/24/2003 | US20030078193 Therapeutic Agents For Diabetes |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077802 Human PRL1 phosphatase |
| 04/24/2003 | US20030077798 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's, diabetes and inflammation |
| 04/24/2003 | US20030077749 Ucp5 |
| 04/24/2003 | US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/24/2003 | US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 04/24/2003 | US20030077340 Lipid is coconut oil esterified with fatty acid |
| 04/24/2003 | US20030077339 Plant extract for diabetic therapy |
| 04/24/2003 | US20030077331 Calcium glutarate supplement and phosphorus binder |
| 04/24/2003 | US20030077327 Highly compressible ethylcellulose for tableting |
| 04/24/2003 | US20030077291 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077259 Induction of beta cell differentiation in human cells |
| 04/24/2003 | US20030077256 Pancreas regeneration using embryonic pancreatic cells |
| 04/24/2003 | US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | CA2781766A1 Method of stabilizing reduced coenzyme q10 |
| 04/24/2003 | CA2746795A1 Method for crystallizing reduced coenzyme q10 |
| 04/24/2003 | CA2727642A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2494706A1 Chimeric glycosylphosphatidylinositol containing peptides |
| 04/24/2003 | CA2464412A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2cactivity |
| 04/24/2003 | CA2463979A1 Method of producing human beta cell lines |
| 04/24/2003 | CA2463914A1 Conversion of liver stem and progenitor cells to pancreatic functional cells |
| 04/24/2003 | CA2463908A1 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 04/24/2003 | CA2463769A1 Composition and method for treating diabetes |
| 04/24/2003 | CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | CA2463724A1 Organosulfur inhibitors of tyrosine phosphatases |
| 04/24/2003 | CA2463686A1 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/24/2003 | CA2463685A1 Novel .beta.-phenyl-.alpha.-oxysubstituted propionic derivatives: process for its preparation and their use in the preparation of pharmaceutically important compounds |
| 04/24/2003 | CA2463682A1 Method of reducing type 2 diabetes in high risk patients |
| 04/24/2003 | CA2463676A1 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans |
| 04/24/2003 | CA2463624A1 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications |
| 04/24/2003 | CA2463578A1 Differentially expressed genes associated with obesity and type 2 diabetes |
| 04/24/2003 | CA2463518A1 Carbinols for the treatment of neuropathic dysfunction |
| 04/24/2003 | CA2463509A1 Lactam derivatives as antagonists for human 11cby receptors |
| 04/24/2003 | CA2463508A1 Pyrimidinones as melanin concentrating hormone receptor 1 |
| 04/24/2003 | CA2463395A1 Therapeutic agents for low hdl-cholesterolemia |
| 04/24/2003 | CA2462785A1 Kinases and phosphatases |
| 04/24/2003 | CA2462588A1 Ngzipa, ngzipd, pgzipa, and pgzipd polynucleotides and polypeptides and uses thereof |
| 04/24/2003 | CA2462514A1 Dicarboxylic acid derivatives, their preparation and therapeutical use |
| 04/24/2003 | CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | CA2461818A1 Treatment and diagnosis of insulin resistant states |
| 04/24/2003 | CA2461758A1 Use of cystathionine |
| 04/24/2003 | CA2461550A1 Stabilized compositions of aqueous reduced coenzyme q solution |
| 04/24/2003 | CA2461170A1 Peptidyl ketones as inhibitors of dpiv |
| 04/24/2003 | CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | CA2459572A1 Composition comprising a lactobacillus pentosus strain and uses thereof |
| 04/23/2003 | EP1304330A2 Polymorph of 5-[4-[2-(N-Methyl-N-(2-Pyridyl)Amino)Ethoxy]Benzyl]Thiazolidine-2,4-Dione maleic acid salt |
| 04/23/2003 | EP1304327A2 Glutamine-thiazolidide and -pyrrolidide and their use as dipeptidylpeptidase IV inhibitors |
| 04/23/2003 | EP1304324A1 Serotonin reuptake inhibitors |
| 04/23/2003 | EP1304124A1 Diagnostic agent for diabetes comprising 13C labelled compound |
| 04/23/2003 | EP1304121A1 Body weight gain inhibitors |
| 04/23/2003 | EP1304113A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1304112A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303632A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 04/23/2003 | EP1303625A2 Alpha-msh related compounds and methods of use |
| 04/23/2003 | EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 04/23/2003 | EP1303541A1 Gel compositions containing metronidazole |
| 04/23/2003 | EP1303537A2 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303528A1 Adenosine compound and pharmaceutical composition containing the same |
| 04/23/2003 | EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 04/23/2003 | EP1303517A1 Indoloquinazolinones |
| 04/23/2003 | EP1303509A1 Beta3 adrenergic agonists |
| 04/23/2003 | EP1303507A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303503A2 Aniline derivatives |
| 04/23/2003 | EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 04/23/2003 | EP1303499A1 Tetrazole derivatives |
| 04/23/2003 | EP1303495A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303479A2 7-, 8- and 9-substituted tetracycline compounds |
| 04/23/2003 | EP1303477A2 1-amino-alkylcyclohexanes as 5-ht3- and neuronal nicotinicreceptor antagonists |